GHK-Cu: Benefits, Mechanism, and What the Skin Research Shows (2026) Most claims about GHK-Cu benefits come from skincare marketing, not from a careful read of the literature, so the real evidence is worth separating from the sales copy. GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper) that occurs naturally in human plasma, and its … Read more
Epithalon Benefits: What the Telomerase Research Actually Shows (2026) Epithalon (also written epitalon, sequence Ala-Glu-Asp-Gly) is a synthetic four-amino-acid pineal peptide studied mainly for telomere biology and aging. Most claims about epithalon benefits trace back to a single research group and a small body of studies, so the honest version is narrower than the marketing. … Read more
DSIP: Delta Sleep-Inducing Peptide Benefits and Research (2026) Searches for DSIP peptide benefits usually return a tidy list of promises: deeper sleep, less stress, faster recovery. The published record is thinner and older than the marketing suggests. DSIP (delta sleep-inducing peptide) was isolated in 1974, and after fifty years its own biological role is still … Read more
Copper Peptides for Skin: What the Research Actually Shows (2026) Copper peptides for skin sit at an odd intersection: researchers have studied the underlying molecule for decades, while skincare marketing treats the term as shorthand for “good ingredient.” The real category is narrower: one naturally occurring tripeptide and a short list of close relatives. The … Read more
Collagen Peptides Benefits: What the Research Actually Shows (2026) Type “collagen peptides benefits” into a search bar and most results read like ad copy: firmer skin, stronger joints, thicker hair. The real research is narrower, split into distinct products lumped together under one label. The Compound Universe take: Collagen peptides benefits are real but split: … Read more
CJC-1295: Benefits, DAC vs No-DAC, and Research Status (2026) Most claims about CJC-1295 benefits come from marketing pages, not from the small human trial record that actually exists. CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH), and the one thing the published research shows clearly is a long, sustained rise in growth hormone (GH) … Read more
Cerebrolysin: Benefits, Mechanism, and What the Trials Show (2026) Most claims about cerebrolysin benefits come from clinics that sell the infusion, not from the trial record. The honest version is more nuanced: cerebrolysin is a porcine brain-derived mix of small peptides and amino acids that has been tested in thousands of patients for stroke, dementia, … Read more
Category 2 Peptides List: FDA Status Explained (As of July 2026) The category 2 peptides list is the FDA’s own record of compounds the agency says carry too much safety uncertainty to compound under current rules. It started in September 2023 with 19 peptides and has kept moving since, most recently in April 2026, when … Read more
BPC-157 Before and After: What the Research Actually Shows (2026) Most people searching “bpc 157 before and after” want proof: photos or timelines showing a joint, a gut problem, or a soft-tissue injury improving once someone started the peptide. That specific documentation does not exist in the literature. What does exist is a large body … Read more
BPC-157: Benefits, Mechanism, Research, and Legal Status (2026) Most claims about BPC 157 benefits come from animal studies, not human trials, and that distinction changes how you should read every headline about this peptide. BPC-157 is a synthetic 15-amino-acid chain (a pentadecapeptide) derived from a protein found in human gastric juice, and researchers have tested … Read more